These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7755509)

  • 1. The variation of antigen expression: a natural phenomenon utilised for the construction of live recombinant Salmonella vaccines.
    Yan ZX; Meyer TF
    Behring Inst Mitt; 1994 Dec; (95):49-56. PubMed ID: 7755509
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant Salmonella vectors in vaccine development.
    Curtiss R; Kelly SM; Tinge SA; Tacket CO; Levine MM; Srinivasan J; Koopman M
    Dev Biol Stand; 1994; 82():23-33. PubMed ID: 7958478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of Salmonellas as a vector in the designing of recombinant vaccines].
    Boĭchenko MN; Vorobév AA
    Vestn Ross Akad Med Nauk; 1997; (3):43-6. PubMed ID: 9181857
    [No Abstract]   [Full Text] [Related]  

  • 4. Mixed population approach for vaccination with live recombinant Salmonella strains.
    Yan ZX; Meyer TF
    J Biotechnol; 1996 Jan; 44(1-3):197-201. PubMed ID: 8717404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant-attenuated Salmonella vaccines modified to reduce virulence.
    Constable L
    Expert Rev Vaccines; 2011 Aug; 10(8):1117. PubMed ID: 21961199
    [No Abstract]   [Full Text] [Related]  

  • 6. Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system.
    Dougan G; Hormaeche CE; Maskell DJ
    Parasite Immunol; 1987 Mar; 9(2):151-60. PubMed ID: 3106921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design of Salmonella-based vaccination strategies.
    Spreng S; Dietrich G; Weidinger G
    Methods; 2006 Feb; 38(2):133-43. PubMed ID: 16414270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Escherichia coli hemolysin secretion apparatus--a versatile antigen delivery system in attenuated Salmonella.
    Gentschev I; Dietrich G; Mollenkopf HJ; Sokolovic Z; Hess J; Kaufmann SH; Goebel W
    Behring Inst Mitt; 1997 Feb; (98):103-13. PubMed ID: 9382730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stable expression of heterologous proteins in salmonella: problems and approaches to their designing].
    Abaev IV; Svetoch EA; Urakov NN
    Vestn Ross Akad Med Nauk; 1997; (6):48-52. PubMed ID: 9289281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of Salmonella recombinant vaccines.
    Cheminay C; Hensel M
    Int J Med Microbiol; 2008 Jan; 298(1-2):87-98. PubMed ID: 17888730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live bacterial vaccines and their application as carriers for foreign antigens.
    Dougan G; Smith L; Heffron F
    Adv Vet Sci Comp Med; 1989; 33():271-300. PubMed ID: 2648775
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins.
    Husseiny MI; Hensel M
    Vaccine; 2009 Jun; 27(28):3780-7. PubMed ID: 19464562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination strategies using viable carrier systems against intracellular pathogens.
    Hess J; Szalay G; Miko D; Gentschev I; Goebel W; Ladel CH; Kaufmann SH
    Behring Inst Mitt; 1994 Dec; (95):67-79. PubMed ID: 7755511
    [No Abstract]   [Full Text] [Related]  

  • 14. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice.
    Paliwal PK; Bansal A; Sagi SS; Mustoori S; Govindaswamy I
    Clin Immunol; 2008 Jan; 126(1):89-96. PubMed ID: 18024219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral vaccination using recombinant bacteria.
    Schödel F
    Semin Immunol; 1990 Sep; 2(5):341-9. PubMed ID: 2134017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting the immune system: toward new vaccines against intracellular bacteria.
    Hess J; Schaible U; Raupach B; Kaufmann SH
    Adv Immunol; 2000; 75():1-88. PubMed ID: 10879281
    [No Abstract]   [Full Text] [Related]  

  • 17. Stable recombinant avirulent Salmonella vaccine strains.
    Curtiss R; Kelly SM; Gulig PA; Nakayama K
    Adv Exp Med Biol; 1989; 251():33-47. PubMed ID: 2692430
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
    Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
    Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and secretion of bacterial antigens by attenuated Salmonella via the Escherichia coli hemolysin secretion system.
    Gentschev I; Mollenkopf HJ; Sokolovic Z; Ludwig A; Tengel C; Gross R; Hess J; Demuth A; Goebel W
    Behring Inst Mitt; 1994 Dec; (95):57-66. PubMed ID: 7755510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmonellae as oral vaccine carriers.
    Schödel F; Curtiss R
    Dev Biol Stand; 1995; 84():245-53. PubMed ID: 7796961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.